1 / 8

Zika Virus Vaccines Market Expected to Reach $18,697 Million,Globally, by 2022

Zika virus vaccines market analysis has been done based on opportunities to understand different aspects of Zika virus vaccines that are currently clinical trials along with the variants that are projected to gain prominence in future. Key market players are profiled and their strategies are analyzed thoroughly to understand the various technologies adopted by them to manufacture Zika virus vaccines.<br><br><br>

srushtih123
Download Presentation

Zika Virus Vaccines Market Expected to Reach $18,697 Million,Globally, by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Know the Factors that Driving the Growth of Zika Virus Vaccines Market Global Opportunity Analysis and Industry Forecast, 2017-2022

  2. Zika Virus Vaccines Market “Zika virus is affecting people staying in Zika-infested regions and also the infection is linked with many babies being born with underdeveloped brains. This is attributed to the high risk of infection. Zika virus vaccines are gaining popularity, and FDA has passed priority review voucher system for it.” 

  3. Zika Virus Vaccines Market Overview Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects. View Detail Summary of this report: https://www.alliedmarketresearch.com/zika-virus-vaccines-market Zika virus belongs to Flavivirus, a genus of the viruses in the Flaviridae family, and it is transmitted via Aedes mosquito, blood transfusion, sex, and from an infected pregnant woman to her fetus. The infection of this virus can cause adverse effects such as neurological problems and congenital birth defects in the fetus. 

  4. Zika Virus Vaccines Market Currently, nearly more than 22 countries of Latin America have reported active Zika virus infection, which is estimated to surge the demand for Zika vaccines, create new opportunities. However, in November 2016, WHO announced that Zika virus infection is no more epidemic, and is expected to be less prevalent in future, thus restraining the market growth. However, Asia-Pacific is anticipated to account for 35.2% share of the global market in 2017. About 70 countries are detected with mosquito-borne illness worldwide, among which minimum, 19 countries fall in the Asia-Pacific region. Over 100 Zika infection cases are reported in Singapore, and two confirmed cases are recorded in Thailand with Zika-linked microcephaly up to 2016. Therefore, rise in threat of Zika infection in Asia-Pacific is expected to create potential opportunities for key players. The key players profiled in the report include Immunovaccine Inc., Takeda Pharmaceutical Co. Ltd., Bharat Biotech International Ltd., NewLink Genetics Co., Inovio Pharmaceuticals, Inc., GeneOne Life Science Inc., GlaxoSmithKline plc. Sanofi S.A., and Hawaii Biotech Inc. 

  5. Zika Virus Vaccines Market The recent outbreak of Zika virus infection in Latin American countries reports many cases of transmission from an infected mother to her fetus. Infants are born with microcephaly and related birth defects. According to the Brazilian authorities, more than 1,638 babies were born in the country with microcephaly-related birth defects since 2014; however, no medical options are available for the treatment of these infants. This incidence presents the need for vaccines to prevent this disease, which in turn provides momentum to vaccine manufacturers for the development of vaccines at a rapid pace. Moreover, FDA’s classification of Zika virus infection as a public health emergency and vaccines for preventing Zika infection would be evaluated under priority review voucher, accelerating the time to market the vaccine. Further, from the end user perspectives, the alarming rate of infection of this virus and its effects are expected to increase the awareness levels of the populace and boost the adoption of these vaccines. Hence, awareness and Zika-linked diseases such as microcephaly is expected to offer opportunities to key vaccine manufacturers during the forecast period. 

  6. Key Benefits of Zika Virus Vaccines Market • In-depth study of the global Zika virus vaccines market was conducted based on the current disease prevalence, target population, and pricing for generating market size & forecast from 2017 to 2022 • Zika virus vaccines market analysis has been done based on opportunities to understand different aspects of Zika virus vaccines that are currently clinical trials along with the variants that are projected to gain prominence in future • Key market players are profiled and their strategies are analyzed thoroughly to understand the various technologies adopted by them to manufacture Zika virus vaccines 

  7. Zika Virus Vaccines Market North America Europe Asia-Pacific LAMEA

  8. Zika Virus Vaccines Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/1817 Follow Us On

More Related